EID Parry (India) Ltd
EID Parry (India) Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Top 10 Food Products companies on management guidance
See the sector's top 10 — free with your mobile number.
EID Parry (India) Ltd Q1 FY27 key numbers
- Revenue
- Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. 100 crores turnover with substantially better margins than white sugar.
As stated in EID Parry (India) Ltd's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.
The short version
Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health. - Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters. - CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity. - Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. Core sugar and biofuels business aims for consistent EBITDA generation with efficiency and cost improvements, especially in underperforming states (Page 12).
From EID Parry (India) Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health.
- Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters.
- CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity.
- Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. 100 crores turnover with substantially better margins than white sugar.
2 more points from EID Parry (India) Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what EID Parry (India) Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is commissioning a new jaggery plant in Karnataka within 6 months, which will more than double current jaggery capacity.
- The new jaggery plant is expected to contribute about Rs. 100 crores in turnover.
- The company is focusing on growing the consumer product group (CPG) business, including value-added products like jaggery and brown sugar.
- Exploring new product categories both organically and inorganically.
- Working on monetization of non-core assets (mainly land parcels) to reduce debt, expected to happen in FY '27.
2 more points from EID Parry (India) Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what EID Parry (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what EID Parry (India) Ltd said on order book & pipeline — free account, 30 seconds.
What the Q1 FY27 call signalled
0 of 3 strong
EID Parry (India) Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹7.9K Cr, net loss ₹287 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What EID Parry's management said in earlier quarters
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Food Products this season
- Wardwizard Foods (Q1 FY27)
Revenue for Q1 FY27 (June 2026 quarter) is ₹17.03 Cr, up from ₹13.20 Cr in Q1 FY26, reflecting a strong year-on-year growth. Key investor presentation takeaways
- Chemkart India (Q1 FY27)
Revenue from operations for Apr–Jun FY27 reported at INR 99.60 crore (INR 9,960.22 lakhs). Key investor presentation takeaways from Chemkart India Ltd's Q1 FY27
- Sheetal Cool (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
EID Parry (India) Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were EID Parry (India) Ltd Q1 FY27 results?
Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health. - Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters. - CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity. - Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. Core sugar and biofuels business aims for consistent EBITDA generation with efficiency and cost improvements, especially in underperforming states (Page 12).
What is EID Parry (India) Ltd share price analysis?
EID Parry (India) Ltd currently shows a neutral. The stock trades at a P/E of 15.2 with a market cap of ₹12,346 Cr. Investors should review the full earnings analysis for detailed insights.
Is EID Parry (India) Ltd planning capital expenditure?
- The company is commissioning a new jaggery plant in Karnataka within 6 months, which will more than double current jaggery capacity. - The new jaggery plant is expected to contribute about Rs.
Keep EID Parry (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.